Overview

A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder

Status:
Unknown status

Trial end date:
2013-04-01

Target enrollment:

Participant gender:

Summary

It's a double blind, placebo controlled study to assess the efficacy of Propantheline Bromide to treat overactive bladder (OAB) in HTLV 1 infected patients. We think that the treatment of the OAB with Propantheline could reduce nocturia and frequency in sixty percent.

Phase:

Phase 1

Details

Lead Sponsor:

Hospital Universitário Professor Edgard Santos

Treatments:

Bromides
Propantheline